title: Lysophosphatidic acid stimulates astrocyte proliferation through LPA1.
abstract: Lysophosphatidic acid (LPA) is an extracellular lipid mediator that regulates nervous system development and functions through multiple types of LPA receptors. Here we explore the role of LPA receptor subtypes in cortical astrocyte functions. Astrocytes cultured under serum-free conditions were found to express the genes of five LPA receptor subtypes, lpa1 to lpa5. When astrocytes were treated with dibutyryl cyclic adenosine monophosphate, a reagent inducing astrocyte differentiation or activation, lpa1 expression levels remained unchanged, but those of other LPA receptor subtypes were relatively reduced. LPA stimulated DNA synthesis in both undifferentiated and differentiated astrocytes, but failed to do so in astrocytes prepared from mice lacking lpa1 gene. LPA also inhibited [3H]-glutamate uptake in both undifferentiated and differentiated astrocytes; and LPA-induced inhibition of glutamate uptake was still observed in lpa1-deficient astrocytes. Taken together, these observations demonstrate that LPA1 mediates LPA-induced stimulation of cell proliferation but not inhibition of glutamate uptake in astrocytes.
authors: Division of Molecular Neurobiology, Department of Life Sciences, School of Science and Engineering, Kinki University, Kowakae 3-4-1, Higashiosaka 577-8502, Japan.
authors: Shinya
authors: S
authors: Shano
authors: Ryutaro
authors: R
authors: Moriyama
authors: Jerold
authors: J
authors: Chun
authors: Nobuyuki
authors: N
authors: Fukushima
mesh_terms: D000818:Animals; D001253:Astrocytes / Q000166:cytology / Q000187:drug effects* / Q000378:metabolism; D001483:Base Sequence; D049109:Cell Proliferation / Q000187:drug effects*; D017931:DNA Primers; D005260:Female; D018698:Glutamic Acid / Q000378:metabolism; D006801:Humans; D008246:Lysophospholipids / Q000494:pharmacology*; D008297:Male; D051379:Mice; D008813:Mice, Inbred ICR; D020133:Reverse Transcriptase Polymerase Chain Reaction
chemical_list: D017931:DNA Primers; D008246:Lysophospholipids; D018698:Glutamic Acid; C032881:lysophosphatidic acid
references: J Biol Chem. 2003 Jul 11;278(28):25600-6
references: 12724320
references: Mol Cell Neurosci. 2002 Jul;20(3):415-28
references: 12139919
references: Mol Pharmacol. 2003 Nov;64(5):1199-209
references: 14573770
references: Nat Neurosci. 2003 Dec;6(12):1292-9
references: 14625558
references: Annu Rev Biochem. 2004;73:321-54
references: 15189145
references: Differentiation. 1980;17(1):51-61
references: 6250934
references: Biochem J. 1993 May 1;291 ( Pt 3):677-80
references: 8489494
references: Am J Physiol. 1995 May;268(5 Pt 2):H2048-55
references: 7771554
references: J Neurochem. 1996 Dec;67(6):2300-5
references: 8931461
references: J Neurosci. 1997 Feb 1;17(3):932-40
references: 8994048
references: Mol Pharmacol. 1997 Jul;52(1):6-15
references: 9224806
references: J Neurochem. 1997 Sep;69(3):1073-84
references: 9282930
references: Mol Pharmacol. 1998 Mar;53(3):355-69
references: 9495799
references: J Comp Neurol. 1998 Sep 7;398(4):587-98
references: 9717712
references: Glia. 1999 Oct;28(1):25-33
references: 10498819
references: Neurotox Res. 2005 Nov;8(3-4):221-5
references: 16371316
references: J Biol Chem. 2006 Aug 18;281(33):23589-97
references: 16774927
references: Exp Cell Res. 1999 Nov 25;253(1):230-8
references: 10579925
references: Glia. 1999 Dec;28(3):272-6
references: 10559786
references: Neurochem Int. 2007 Jan;50(2):302-7
references: 17056154
references: Neurochem Res. 2000 May;25(5):573-82
references: 10905618
references: Mol Pharmacol. 2000 Nov;58(5):895-902
references: 11040035
references: Dev Biol. 2000 Dec 1;228(1):6-18
references: 11087622
references: Proc Natl Acad Sci U S A. 2000 Nov 21;97(24):13384-9
references: 11087877
references: Annu Rev Pharmacol Toxicol. 2001;41:507-34
references: 11264467
references: Brain Res. 2003 Nov 14;990(1-2):182-94
references: 14568343